Ikram Hammi
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 10%
- Long-Term Effects of COVID-19
Papers in
-
- Inflammasome and immune disorders 2
- Mitochondrial Function and Pathology 1
-
- Research on Leishmaniasis Studies 4
- Co-authors
- Khadija Akarid (6 shared papers)Fadila Guessous (3 shared papers)Dana J. Philpott (1 shared paper)Nathaniel J. Winsor (1 shared paper)Fraser Soares (1 shared paper)Ali A. Abdul‐Sater (1 shared paper)Samuel A. Killackey (1 shared paper)Stephen E. Girardin (1 shared paper)
- Journals
- Microbial Pathogenesis (3 papers)Cytokine (2 papers)Molecular Cell (1 paper)Experimental Parasitology (1 paper)
- Partner nations
- MoroccoFranceUnited States
In The Last Decade
Ikram Hammi
6 papers receiving 304 citations
Ikram Hammi's Hit Papers
Peers
Comparison fields: 5 of 74
- Infectious Diseases 124
- Neurology 79
- Drug Discovery 1
- Biological Psychiatry 6
- Immunology 49
Countries citing papers authored by Ikram Hammi
This map shows the geographic impact of Ikram Hammi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ikram Hammi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ikram Hammi more than expected).
Fields of papers citing papers by Ikram Hammi
This network shows the impact of papers produced by Ikram Hammi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ikram Hammi. The network helps show where Ikram Hammi may publish in the future.
Co-authors
The 14 scholars most cited alongside Ikram Hammi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong? Hit paper breakdown → | 2021 | 239 |
| 2 | 2022 | 53 | |
| 3 | 2020 | 10 | |
| 4 | 2023 | 6 | |
| 5 | 2022 | 1 | |
| 6 | 2025 | 1 | |
| 7 | 2024 | 0 |
About Ikram Hammi
Ikram Hammi is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health, Infectious Diseases, Epidemiology and Immunology, having authored 7 papers that have together received 310 indexed citations. Recurring topics across this work include Research on Leishmaniasis Studies (4 papers), Trypanosoma species research and implications (2 papers), Inflammasome and immune disorders (2 papers), COVID-19 Clinical Research Studies (2 papers), Endoplasmic Reticulum Stress and Disease (1 paper), Mitochondrial Function and Pathology (1 paper), Toxin Mechanisms and Immunotoxins (1 paper) and Urticaria and Related Conditions (1 paper). The work is most often cited by research in Infectious Diseases (124 citations), Neurology (79 citations), Drug Discovery (1 citation), Biological Psychiatry (6 citations) and Immunology (49 citations). Ikram Hammi has collaborated with scholars based in Morocco, France and United States. Frequent co-authors include Khadija Akarid, Fadila Guessous, Dana J. Philpott, Nathaniel J. Winsor, Fraser Soares, Ali A. Abdul‐Sater, Samuel A. Killackey, Stephen E. Girardin, Damien Arnoult and Myriam Riyad. Their work appears in journals such as Microbial Pathogenesis, Cytokine, Molecular Cell and Experimental Parasitology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.